FDA reverses course on Moderna flu shot
FDA reverses course on Moderna flu shot is drawing significant interest across the industry.
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the company's application to market the new kind of influenza vaccine.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- New 2000-seat theatre construction begins in Canberra
- Sanjay Manjrekar accuses Suryakumar Yadav of 'taking things a bit too far' amid T20 World Cup 2026
- Gordon Ramsay finally unveils the renovations to his £7.5M London mansion in new Netflix series after two years of planning rows
- Alphonso yield could plummet 80% in Konkan
Source: Original →